“Performance and clinical decision-making using the prognostic 40-gene expression profile (40-GEP) test in 1,018 patients with high-risk cutaneous squamous cell carcinoma (SCC)” (2022) SKIN The Journal of Cutaneous Medicine, 6(6), p. s96. doi:10.25251/skin.6.supp.96.